Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Qiagen ( (QGEN) ) is now available.
Qiagen disclosed that the Dutch Financial Markets Authority (AFM) has published a substantial shareholding notification indicating that DWS Investment GmbH holds 3,502,149 ordinary shares in Qiagen, corresponding to a 1.69% capital interest and 2.98% of voting rights, all held directly and on a real (not potential) basis. The announcement, which Qiagen notes is based solely on information from the AFM’s public register, highlights a notable institutional investor position in the company’s shareholder base but does not imply any operational changes, leaving the primary implication at the level of ownership structure and voting influence.
The most recent analyst rating on (QGEN) stock is a Buy with a $62.00 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Qiagen N.V., based in Venlo, the Netherlands, is a life sciences and molecular diagnostics company whose shares are listed on multiple European exchanges as well as the NYSE and Swiss markets, giving it broad international capital-market exposure.
Average Trading Volume: 1,650,733
Technical Sentiment Signal: Buy
Current Market Cap: $11.47B
For detailed information about QGEN stock, go to TipRanks’ Stock Analysis page.